Ferguson Wellman Capital Management, Inc / TMO
Ferguson Wellman Capital Management, Inc’s Thermo Fisher Scientific Inc Position
Does Ferguson Wellman Capital Management, Inc own Thermo Fisher Scientific Inc (TMO)? Yes — 22.4K shares worth $11M (+0.15% of its 13F portfolio) as of Q1 2026, down from 22.7K shares the prior filed quarter.
Position Value
$11M
Q1 2026
Shares
22.4K
% of Portfolio
+0.15%
Quarters Held
30
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 22.4K | $11M | +0.15% |
| Q4 2025 | 22.7K | $13M | +0.21% |
| Q3 2025 | 24.4K | $12M | +0.19% |
| Q2 2025 | 25.1K | $10M | +0.18% |
| Q1 2025 | 29.9K | $15M | +0.29% |
| Q4 2024 | 103.2K | $54M | +1.02% |
| Q3 2024 | 110.6K | $68M | +1.32% |
| Q2 2024 | 112.0K | $62M | +1.26% |
| Q1 2024 | 118.9K | $69M | +1.41% |
| Q4 2023 | 116.9K | $62M | +1.39% |
| Q3 2023 | 114.9K | $58M | +1.42% |
| Q2 2023 | 115.3K | $60M | +1.41% |
| Q1 2023 | 114.4K | $66M | +1.66% |
| Q4 2022 | 93.5K | $51M | +1.34% |
| Q3 2022 | 93.9K | $48M | +1.86% |
| Q2 2022 | 75.9K | $41M | +1.53% |
| Q1 2022 | 75.9K | $45M | +1.41% |
| Q4 2021 | 77.9K | $52M | +1.51% |
| Q3 2021 | 78.2K | $45M | +1.44% |
| Q2 2021 | 78.0K | $39M | +1.28% |
| Q1 2021 | 109.6K | $50M | +1.74% |
| Q4 2020 | 125.4K | $58M | +1.43% |
| Q3 2020 | 125.4K | $55M | +1.53% |
| Q2 2020 | 126.5K | $46M | +1.40% |
| Q1 2020 | 157.9K | $45M | +1.68% |
| Q4 2019 | 142.3K | $46M | +1.36% |
| Q3 2019 | 142.3K | $41M | +1.32% |
| Q2 2019 | 142.2K | $42M | +1.39% |
| Q1 2019 | 143.8K | $39M | +1.34% |
| Q4 2018 | 190.0K | $43M | +1.63% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ferguson Wellman Capital Management, Inc’s full portfolio or all institutional holders of TMO.